Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.

Castle PE, Rodríguez AC, Burk RD, Herrero R, Hildesheim A, Solomon D, Sherman ME, Jeronimo J, Alfaro M, Morales J, Guillén D, Hutchinson ML, Wacholder S, Schiffman M.

Int J Cancer. 2009 Oct 1;125(7):1649-56. doi: 10.1002/ijc.24525.

2.

A review of human carcinogens--Part B: biological agents.

Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group.

Lancet Oncol. 2009 Apr;10(4):321-2. No abstract available.

PMID:
19350698
3.

High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer.

Hesselink AT, Berkhof J, Heideman DA, Bulkmans NW, van Tellingen JE, Meijer CJ, Snijders PJ.

Int J Cancer. 2009 Jan 15;124(2):381-6. doi: 10.1002/ijc.23940.

4.

Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.

Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY.

Cancer Res. 2008 Nov 1;68(21):8813-24. doi: 10.1158/0008-5472.CAN-08-1380.

5.

Persistence of genital human papillomavirus infection in a long-term follow-up study of female university students.

Sycuro LK, Xi LF, Hughes JP, Feng Q, Winer RL, Lee SK, O'Reilly S, Kiviat NB, Koutsky LA.

J Infect Dis. 2008 Oct 1;198(7):971-8. doi: 10.1086/591625.

PMID:
18694334
6.

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC.

Lancet Oncol. 2008 May;9(5):425-34. doi: 10.1016/S1470-2045(08)70103-7. Epub 2008 Apr 11.

PMID:
18407790
7.

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Rodríguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, Solomon D, Burk R; Proyecto Epidemiológico Guanacaste Group.

J Natl Cancer Inst. 2008 Apr 2;100(7):513-7. doi: 10.1093/jnci/djn044. Epub 2008 Mar 25.

8.

Human papillomaviruses.

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.

IARC Monogr Eval Carcinog Risks Hum. 2007;90:1-636. No abstract available.

9.

CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.

Carreon JD, Sherman ME, Guillén D, Solomon D, Herrero R, Jerónimo J, Wacholder S, Rodríguez AC, Morales J, Hutchinson M, Burk RD, Schiffman M.

Int J Gynecol Pathol. 2007 Oct;26(4):441-6.

PMID:
17885496
10.

High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.

Gravitt PE, Kovacic MB, Herrero R, Schiffman M, Bratti C, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Rodriguez AC, Burk RD.

Int J Cancer. 2007 Dec 15;121(12):2787-93.

11.

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial.

Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, Schiller JT, Gonzalez P, Dubin G, Porras C, Jimenez SE, Lowy DR; Costa Rican HPV Vaccine Trial Group.

JAMA. 2007 Aug 15;298(7):743-53.

PMID:
17699008
12.

A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.

Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM; ALTS Group.

J Infect Dis. 2007 Jun 1;195(11):1582-9. Epub 2007 Apr 16.

PMID:
17471427
13.

The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.

Rodriguez AC, Burk R, Herrero R, Hildesheim A, Bratti C, Sherman ME, Solomon D, Guillen D, Alfaro M, Viscidi R, Morales J, Hutchinson M, Wacholder S, Schiffman M.

Sex Transm Dis. 2007 Jul;34(7):494-502.

PMID:
17237737
14.

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period.

Kjaer S, Høgdall E, Frederiksen K, Munk C, van den Brule A, Svare E, Meijer C, Lorincz A, Iftner T.

Cancer Res. 2006 Nov 1;66(21):10630-6. Epub 2006 Oct 23.

15.

Variations in the age-specific curves of human papillomavirus prevalence in women worldwide.

Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N.

Int J Cancer. 2006 Dec 1;119(11):2677-84.

16.

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M.

J Natl Cancer Inst. 2005 Jul 20;97(14):1072-9.

PMID:
16030305
17.

The carcinogenicity of human papillomavirus types reflects viral evolution.

Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE, Burk RD.

Virology. 2005 Jun 20;337(1):76-84.

18.

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.

Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD.

J Infect Dis. 2005 Jun 1;191(11):1808-16. Epub 2005 May 2.

PMID:
15871112
19.

Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.

Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD.

J Infect Dis. 2005 Jun 1;191(11):1796-807. Epub 2005 May 2.

PMID:
15871111
20.

Carcinogenicity of human papillomaviruses.

Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F; WHO International Agency for Research on Cancer.

Lancet Oncol. 2005 Apr;6(4):204. No abstract available.

PMID:
15830458

Supplemental Content

Support Center